Biochemicals start-up Amyris raised about $85 million in an IPO late last week, reports say. The company went public at $16/share, below a previously announced target of $18-$20/share. It closed at ...
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.